Bionano Genomics (BNGO) Change in Receivables (2017 - 2026)
Bionano Genomics (BNGO) posted Change in Receivables of -$1.1 million for Q1 2026, down 258.31% sequentially from $674000.0 in Q4 2025, and up 23.68% YoY from -$862733.4 in Q1 2025.
Bionano Genomics (BNGO) Change in Receivables (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Change in Receivables for 10 years, with the latest figure at -$1.1 million in Q1 2026.
- Quarterly Change in Receivables rose 23.68% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $779000.0 (up 117.19% YoY) and the FY2025 annual result came in at $448000.0, up 110.82% from the prior year.
- Change in Receivables fell to -$1.1 million in Q1 2026 per BNGO's latest filing, from $674000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $1.2 million in Q3 2022 and troughed at -$2.1 million in Q2 2024.
- A 5-year average of -$12411.8 and a median of $141000.0 in 2025 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables soared 611.46% in 2022, then slumped 347.6% in 2024.
- Over 5 years, Change in Receivables stood at $1.1 million in 2022, then sank by 41.81% to $650000.0 in 2023, then tumbled by 120.46% to -$133000.0 in 2024, then soared by 606.77% to $674000.0 in 2025, then sank by 258.31% to -$1.1 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$1.1 million, $674000.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 74.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 37.21 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 252.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 156.00 Mn |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn | 233,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 233,000.00 |
| Jun 30, 2026 | 233,000.00 |
| Mar 31, 2026 | -1.07 Mn |
| Mar 31, 2026 | -1.07 Mn |
| Dec 31, 2025 | 674,000.00 |
| Dec 31, 2025 | 674,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 141,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | -1.40 Mn |
| Mar 31, 2025 | -1.40 Mn |
| Dec 31, 2024 | -133,000.00 |
| Dec 31, 2024 | -133,000.00 |
| Sep 30, 2024 | -942,000.00 |
| Sep 30, 2024 | -942,000.00 |
| Jun 30, 2024 | -2.06 Mn |
| Jun 30, 2024 | -2.06 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Mar 31, 2024 | -1.00 Mn |